EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, American Bio Medica's enterprise value is $0.20 Mil.
American Bio Medica's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was $1.07 Mil. Therefore, American Bio Medica's EV-to-EBITDA for today is 0.19.
The historical rank and industry rank for American Bio Medica's EV-to-EBITDA or its related term are showing as below:
ABMC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.2
Current: 0.19
During the past 13 years, the highest EV-to-EBITDA of American Bio Medica was 0.20. The lowest was 0.00. And the median was 0.00.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
American Bio Medica EV-to-EBITDA Historical Data
The historical data trend for American Bio Medica's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of American Bio Medica's EV-to-EBITDA
For the Diagnostics & Research subindustry, American Bio Medica's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
American Bio Medica's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, American Bio Medica's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where American Bio Medica's EV-to-EBITDA falls into.
American Bio Medica's current Enterprise Value is $0.20 Mil.
American Bio Medica's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.07 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
American Bio Medica (OTCPK:ABMC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
American Bio Medica's PE Ratio for today is calculated as:
American Bio Medica's share price for today is $0.002.
American Bio Medica's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of American Bio Medica's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
American Bio Medica (American Bio Medica) Business Description
American Bio Medica Corp is a us-based company engaged in manufacturing and selling lateral flow immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids at the point of collection. It also manufactures and sells drug testing products and provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. The company offers few urine tests which include Rapid Drug Screen, RDS InCup, Rapid TOX, and Rapid TOX Cup II. Its target customer includes workplace, government, corrections, clinical and educational markets. Geographically, it derives a majority of revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABMC has been successfully added to your 